Budi Oetomo Narendra 
Hendra Lukman 
Gilang Cahya 
Billy Candra 
Nana O Roche’s Amylin-Targeting Obesity Drug Petrelintide Underperforms in Phase 2, Raising Questions on Market Competitiveness
admin Basel, Switzerland – Hopes for Roche’s amylin-targeting obesity drug, petrelintide, have been tempered following the...
Servier to Acquire Day One Biopharmaceuticals in Multibillion-Dollar Deal to Bolster Rare Oncology Portfolio
French pharmaceutical giant Servier has reached a definitive agreement to acquire Day One Biopharmaceuticals, a...
New iron nanomaterial wipes out cancer cells without harming healthy tissue
The Oregon State Breakthrough: A New Era in Chemodynamic Therapy The core of this transformative...
Unraveling the Gut-Heart Connection: How Microbes May Drive Coronary Artery Disease
Cardiovascular diseases, particularly coronary artery disease (CAD), tragically claim nearly 20 million lives each year,...
Unraveling the Paradox: How Polyamines Drive Both Healthy Aging and Aggressive Cancer Growth
Polyamines, ubiquitous molecules present in all living cells, have long captivated scientific interest due to...
Brazilian Researchers Identify Protein Pathway Driving Early Nerve Invasion in Pancreatic Cancer
Gabriel Paijo The landscape of oncology is being reshaped by a significant discovery from Brazil, where researchers...
The Universal Pet Effect on Human Well-being Questioned by New Lockdown Study
A groundbreaking study conducted during the unprecedented circumstances of the COVID-19 lockdowns has cast doubt...
Breakthrough in Sperm Metabolism Research at Michigan State University Unlocks New Potential for Male Contraception and Infertility Treatments
In a landmark study that could redefine the landscape of reproductive medicine, researchers at Michigan...
Unmasking the Hidden Complexity of Toxoplasma Gondii Cysts: UC Riverside Researchers Reveal New Parasite Subtypes and Pathways for Future Treatments
George Ongkojoyo The parasitic landscape of the human body is far more intricate than previously documented, as...
Forskolin Shows Promising Potential to Revolutionize Treatment for Aggressive KMT2A-Rearranged Acute Myeloid Leukemia
A groundbreaking study emerging from the University of Surrey is illuminating a potential new avenue...
